Analysts expect Moderna to report an earnings per share (EPS) of $-2.98.
Investors in Moderna are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Earnings History Snapshot
The company's EPS beat by $0.66 in the last quarter, leading to a 2.15% increase in the share price on the following day.
Here's a look at Moderna's past performance and the resulting price change:
Quarter
Q1 2025
Q4 2024
Q3 2024
Q2 2024
EPS Estimate
-3.18
-2.68
-1.90
-3.39
EPS Actual
-2.52
-2.91
0.03
-3.33
Price Change %
2.0%
3.0%
-7.000000000000001%
-8.0%
Moderna Share Price Analysis
Shares of Moderna were trading at $32.15 as of July 30. Over the last 52-week period, shares are down 64.15%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
Analysts' Take on Moderna
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Moderna.
Analysts have given Moderna a total of 6 ratings, with the consensus rating being Neutral. The average one-year price target is $36.83, indicating ...
